Correlation Between Estrella Immunopharma and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Estrella Immunopharma and Citius Oncology,, you can compare the effects of market volatilities on Estrella Immunopharma and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Citius Oncology,.
Diversification Opportunities for Estrella Immunopharma and Citius Oncology,
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Estrella and Citius is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Citius Oncology, go up and down completely randomly.
Pair Corralation between Estrella Immunopharma and Citius Oncology,
Assuming the 90 days horizon Estrella Immunopharma is expected to generate 3.04 times more return on investment than Citius Oncology,. However, Estrella Immunopharma is 3.04 times more volatile than Citius Oncology,. It trades about 0.19 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.2 per unit of risk. If you would invest 3.62 in Estrella Immunopharma on September 1, 2024 and sell it today you would earn a total of 5.48 from holding Estrella Immunopharma or generate 151.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 64.1% |
| Values | Daily Returns |
Estrella Immunopharma vs. Citius Oncology,
Performance |
| Timeline |
| Estrella Immunopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
| Citius Oncology, |
Estrella Immunopharma and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Estrella Immunopharma and Citius Oncology,
The main advantage of trading using opposite Estrella Immunopharma and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Estrella Immunopharma vs. Tff Pharmaceuticals | Estrella Immunopharma vs. Eliem Therapeutics | Estrella Immunopharma vs. Inhibrx | Estrella Immunopharma vs. Enliven Therapeutics |
| Citius Oncology, vs. Verve Therapeutics | Citius Oncology, vs. Beam Therapeutics | Citius Oncology, vs. Caribou Biosciences | Citius Oncology, vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |